We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App





Isothermal Amplification Based COVID-19 Test System Could Detect Any Coronavirus Variant

By LabMedica International staff writers
Posted on 29 Dec 2021

Researchers have developed a strategy to create a cheap and rapid COVID-19 test based on isothermal amplification that will make it possible to create universal test systems for any of the COVID-19 variants. More...

The strategy developed by researchers at the HSE University (Moscow, Russia) will decrease the cost of COVID-19 tests considerably and speed up the process, since no specially trained professionals or expensive equipment will be needed. There are several options for systems that detect traces of SARS-CoV-2 in human blood or secretion samples. They usually detect either scraps of COVID-19’s pathogen RNA using polymerase chain reaction (PCR) and its analogues, or antibodies to COVID-19. Usually, quite a lot of time is required for such a test, from 30 minutes to several hours, which is why researchers are looking for new, faster methods to detect antibodies or COVID infection.

The Russian researchers have been working on another alternative to PCR tests that is based on so-called loop-mediated isothermal amplification (LAMP). This testing approach allows for multiplication of certain DNA or RNA fragments from bio samples with the use of special markers and ferments of extremophilic bacteria that reside in hot springs. The key advantage of LAMP over PCR is that all reactions can be made at the same temperature. This simplifies and speeds up the process. But these systems are much more complicated to develop and have a few drawbacks, which has previously limited their use in COVID-19 test systems. The new strategy developed by the researchers will help overcome these drawbacks and give healthcare professionals an opportunity to use LAMP testing to detect traces of any COVID variants in samples of mucus and blood without preliminary processing in a laboratory.

Related Links:
HSE University 


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.